Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections

Siegman-Igra, Yardena; Schwartz, Doron; Soferman, G; Konforti, N

doi:10.1007/bf00200682

Cited by 33 publications

(30 citation statements)

References 26 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this work we demonstrate that flavobacteria and flavobacteria-like organisms produce APs when grown in the presence of freely available P i . As a representative enzyme, we further studied that produced by C. meningosepticum, which is the most relevant species in this group from the medical standpoint (Siegman-Igra et al, 1987). Similar to the PhoA-like enzymes, also this AP activity was apparently secreted into the periplasmic space, although at present we can not establish whether it is found as a (Peiffer et al, 1996) or the PhoV enzyme of Synechococcus (Wagner et al, 1995).…”

Section: Discussionmentioning

confidence: 98%

The Chryseobacterium meningosepticum PafA enzyme: prototype of a new enzyme family of prokaryotic phosphate-irrepressible alkaline phosphatases? The GenBank accession number for pafA reported in this paper is AF157621.

et al. 2001

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 98%

The Chryseobacterium meningosepticum PafA enzyme: prototype of a new enzyme family of prokaryotic phosphate-irrepressible alkaline phosphatases? The GenBank accession number for pafA reported in this paper is AF157621.

et al. 2001

View full text Add to dashboard Cite

“…Flavobacterium) is a group of non-glucose-fermenting gramnegative rods (15). These bacteria are typically found in freshwater, saltwater, or soil and are not normally present in the human microflora (2,15).…”

Section: Discussion the Genus Chryseobacterium (Formerly Known Asmentioning

confidence: 99%

“…These bacteria are typically found in freshwater, saltwater, or soil and are not normally present in the human microflora (2,15). C. meningosepticum is the species most commonly reported as a human pathogen within the genus Chryseobacterium and was initially described for a case of neonatal meningitis in 1959 (9).…”

Section: Discussion the Genus Chryseobacterium (Formerly Known Asmentioning

confidence: 99%

“…Although published data about the antimicrobial susceptibilities of clinical Chryseobacterium isolates are limited and the MIC breakpoints have not been established by the Clinical and Laboratory Standards Institute (5), Chryseobacterium isolates are regarded as resistant to many antimicrobial agents commonly prescribed for gram-negative infections, including expanded-spectrum and broad-spectrum cephalosporins, carbapenems, and aminoglycosides (6,7,15). However, in vitro susceptibilities determined by the disk diffusion method have been shown to poorly correlate with those by the broth microdilution method, which is the preferred methodology (6).…”

Section: Discussion the Genus Chryseobacterium (Formerly Known Asmentioning

confidence: 99%

“…They hydrolyzed esculin and could produce acid from mannitol (13,15). They were identified as Chryseobacterium meningosepticum by means of the API 20NE system (BioMerieux, Marcy l'Etoile, France) and the GNI Plus system (Vitek Systems, BioMerieux, Vitek, Hazelwood, Mo.).…”

mentioning

confidence: 99%

See 2 more Smart Citations

Fatal Case of Community-Acquired Bacteremia and Necrotizing Fasciitis Caused by Chryseobacterium meningosepticum : Case Report and Review of the Literature

Lee¹,

Chen²,

Wang

et al. 2006

J Clin Microbiol

View full text Add to dashboard Cite

A diabetic patient with chronic heart failure developed necrotizing fasciitis and bacteremia caused by Chryseobacterium meningosepticum, which rapidly evolved into death, even with fasciotomy and intensive care. A review of the English literature found 10 cases of soft tissue infection caused by C. meningosepticum, which is rarely acquired in the community. CASE REPORTA 62-year-old diabetic man with coronary artery and rheumatic heart disease received a mitral valve replacement by mechanical valve and coronary artery bypass in October 2000. He took regular medications, including oral warfarin, glibenclamide, metformin hydrochloride (Glucophage), digoxin, and furosemide. In January 2005, he developed bilateral lower-leg edema, progressive dyspnea, orthopnea, and a decline in urine output for 3 days until erythema and exquisite pain of the left lower leg made him visit the emergency department of the hospital. He denied fever, chills, and a history of trauma and contact with water. On initial physical examination, he had a blood pressure of 66/48 mm Hg, a pulse rate of 78/min, a body temperature of 37.8°C, and a respiratory rate of 22/min. He had feeling in his left lower limb. Some bullae with clear content and erythematous skin were observed. Initial laboratory tests showed leukocytosis with a left shift (17,200 cells/ mm 3 with 30% band form). The serum level of C-reactive protein was 39.1 mg/liter. Acute renal failure (serum creatinine, 2.4 mg/dl) and an elevated aspartate aminotransferase level (64 U/liter) were found. Chest X-ray film showed marked cardiomegaly and bilateral pulmonary congestion. Cardiac sonography revealed four-chamber dilation and global hypokinesis with impaired performance of the left ventricle. Medical therapy for cardiogenic shock was instituted, and empirical antibiotic with intravenous cefpirome was administrated. Color duplex sonography of the left lower leg revealed no evidence of deep vein thrombosis.On the next day, more tenderness and hemorrhagic bullae were noted for his left lower leg (Fig. 1). Intravenous ciprofloxacin was initiated based on initial susceptibility results by the disk diffusion technique. On the third day, fasciotomy was undergone, and he was then admitted into the intensive care unit. However, clinical evolution was rapid, and a loss of consciousness, anuria, and multiple organ failure developed. He died on the fourth day.Nonfermentative, catalase-and oxidase-positive gram-negative rods were discovered in the blood and wound, and both yielded slightly yellow-pigmented colonies on blood agar after 24 h of incubation. They hydrolyzed esculin and could produce acid from mannitol (13, 15). They were identified as Chryseobacterium meningosepticum by means of the API 20NE system (BioMerieux, Marcy l'Etoile, France) and the GNI Plus system (Vitek Systems, BioMerieux, Vitek, Hazelwood, Mo.). The MICs of selected antimicrobial agents measured by E-test strips (AB Biodisk, Solona, Sweden) were 0.38 g/ml for levofloxacin, 0.25 g/ml for ciprofloxacin, 0.06-0.32 g/ml for ...

show abstract

Chryseobacterium

Bernardet¹,

Hugo²,

Bruun³

2015

Bergey's Manual of Systematics of Archaea and Bacteria

View full text Add to dashboard Cite

Chry.se.o.bac.te'ri.um. Gr. adj. chryseos golden; L. neut. n. bacterium a small rod; N.L. neut. n. Chryseobacterium a yellow rod. Bacteroidetes / Flavobacteriia / Flavobacteriales / Flavobacteriaceae / Chryseobacterium Straight, single rods with rounded ends typically about 0.5 µm in width and variable in length, often 1–3 µm; filamentous cells and pleomorphism also occur. Do not form endospores. Spherical degenerative forms do not appear in ageing liquid cultures. Colonies are pale to bright yellow due to the production of non‐diffusible, non‐fluorescent flexirubin‐type pigments . A strong, aromatic odor is produced. Gram‐stain‐negative. Nonmotile. Flagella, gliding movement, or swarming growth have not been reported. Obligately aerobic, having a strictly respiratory type of metabolism with oxygen as the terminal electron acceptor. No denitrification occurs and most species do not reduce nitrate or nitrite . Chemo‐organotrophic. Most environmental isolates grow at 5°C, all grow at 15–30°C, and several grow up to 37°C; clinical isolates do not grow at 5°C, but grow at 15–37°C, and some grow at up to 42°C. Grow readily on the usual commercial media; no growth factors are required. Most species also grow in media containing up to 3–5% NaCl. No growth or weak growth on cetrimide agar, but members of a few species are able to grow on MacConkey agar. Catalase‐ and oxidase‐positive . Several carbohydrates are oxidized. Esculin is hydrolyzed, but agar is not. Strong proteolytic activity occurs. Most strains are resistant to a wide range of antimicrobial agents . Menaquinone‐6 (MK‐6) is the only or predominant respiratory quinone. Predominant cellular fatty acids are C 15:0 iso, C 17:0 iso 3‐OH, C 17:1 iso ω9 c , and summed feature 4 (comprising C 15:0 iso 2‐OH and/or C 16:1 ω7 c / t ). Members of most species occur in soil and in fresh or seawater habitats. Two species and unclassified strains also occur in human clinical specimens and hospital environments, but their pathogenicity to man is not well‐documented. Two species and unclassified strains have been retrieved from diseased fish. Four species occur in food or dairy products; they may be involved in spoilage. DNA G + C content ( mol %): 29–39. Type species : Chryseobacterium gleum (Holmes, Owen, Steigerwalt and Brenner 1984b) Vandamme, Bernardet, Segers, Kersters and Holmes 1994a, 830 VP ( Flavobacterium gleum Holmes, Owen, Steigerwalt and Brenner 1984b, 23).

show abstract

Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections

Cited by 33 publications

References 26 publications

The Chryseobacterium meningosepticum PafA enzyme: prototype of a new enzyme family of prokaryotic phosphate-irrepressible alkaline phosphatases? The GenBank accession number for pafA reported in this paper is AF157621.

The Chryseobacterium meningosepticum PafA enzyme: prototype of a new enzyme family of prokaryotic phosphate-irrepressible alkaline phosphatases? The GenBank accession number for pafA reported in this paper is AF157621.

Fatal Case of Community-Acquired Bacteremia and Necrotizing Fasciitis Caused by Chryseobacterium meningosepticum : Case Report and Review of the Literature

Chryseobacterium

Contact Info

Product

Resources

About